Further research by University Hospitals in Cleveland, examining over 336,000 individuals, discovered that the likelihood of developing gastroparesis increases after six months of GLP-1 therapy
The overall evidence supports a favorable hepatic safety profile, with potential therapeutic benefits for patients with underlying liver disease related to metabolic syndrome
Activated charcoal can adsorb certain substances in the digestive tract, which may support normal digestive elimination
However, always start slowly and consult your healthcare provider before making any significant changes to your routine
Recognizing the warning signs early is important for staying safe and avoiding injury
Antioxid Redox Signal 2:665671 Savaskan NE, Heckl A, Hahnen E, Engelhorn T, Doerfler A, Gansladt O et al (2008) Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema